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Fibrin supports human fetal islet-epithelial cell
differentiation via p70s6k and promotes vascular
formation during transplantation
Matthew Riopel1,2, Jinming Li1,3, Mark Trinder1,3, George F Fellows4 and Rennian Wang1,3,5

The human fetal pancreas expresses a variety of extracellular matrix (ECM) binding receptors known as integrins. A
provisional ECM protein found in blood clots that can bind to integrin receptors and promote β cell function and survival
is fibrin. However, its role in support of human fetal pancreatic cells is unknown. We investigated how fibrin promotes
human fetal pancreatic cell differentiation in vitro and in vivo. Human fetal pancreata were collected from 15 to 21 weeks
of gestation and collagenase digested. Cells were then plated on tissue-culture polystyrene, or with 2D or 3D fibrin gels up
to 2 weeks, or subcutaneously transplanted in 3D fibrin gels. The human fetal pancreas contained rich ECM proteins and
expressed integrin αVβ3. Fibrin-cultured human fetal pancreatic cells had significantly increased expression of PDX-1,
glucagon, insulin, and VEGF-A, along with increased integrin αVβ3 and phosphorylated FAK and p70s6k. Fibrin-cultured
cells treated with rapamycin, the mTOR pathway inhibitor, had significantly decreased phospho-p70s6k and PDX-1
expression. Transplanting fibrin-mixed cells into nude mice improved vascularization compared with collagen controls.
These results suggest that fibrin supports islet cell differentiation via p70s6k and promotes vascularization in human fetal
islet-epithelial clusters in vivo.
Laboratory Investigation (2015) 95, 925–936; doi:10.1038/labinvest.2015.74; published online 1 June 2015

Islet transplantation for the treatment of diabetes is currently
limited by a shortage of available donor pancreata.1 To
surpass this problem, generating β cells from progenitor cell
sources is a viable option.2 However, this procedure and
others like it produce low numbers of effective, functional β
cells.2 A greater understanding of the factors, especially those
in the microenvironment, that regulate pancreatic development and islet cell differentiation is required to significantly
increase the yield of β cells that these procedures generate for
islet transplantation.
Human pancreatic development begins at day 26 post
conception, with tubular structures protruding from the
ventral and dorsal side of the foregut endoderm. Two
transcription factors that are required for the initiation of
pancreatic development are PTF-1A and PDX-1,3 in which
the latter also promotes β cell maturation and function.4 By
8 weeks of age, SOX9 is expressed in the pool of pancreatic
progenitors5 and is essential to support their proliferation and
survival as well as maintain a transcriptional network with
other factors.6 SOX9 is also an important regulator of

pancreatic endocrine cell differentiation.5 Insulin positivity
emerges around 7.5 weeks post conception, followed by
glucagon and somatostatin 1 week later.7 Islet-like structures
eventually form where cells commonly express more than one
hormone.7 Subsequently, clustering occurs leading to construction of the islet of Langerhans.8,9
Cell receptors in the human fetal pancreas that allow
interactions with the extracellular environment (ECM) are
integrins. Integrins are a family of highly expressed heterodimeric α and β receptors that bind to motifs of laminin,
collagen, fibronectin, and other cell-surface receptors.10
Integrins modulate multiple cellular processes in a variety of
tissues. In the mouse pancreas, the conditional removal
of β1 integrin leads to dysfunction of the endocrine11
and exocrine12 compartments. Removal of β1 integrin in
developing pancreatic β cells leads to a massive reduction in
insulin-positive cells and cell-cycle progression genes, suggesting that β cell expansion relies upon β1 integrin and ECM
interactions.13 Meanwhile, studies with human fetal pancreas
indicate that integrins α3, α5 α6, and their associated β1
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counterpart are present by 8 weeks of age, and increase as
development continues.14,15 Also, integrins αv with β1, β3,
and β5 are important for human fetal β cell adhesion and
motility.16–18 Knockdown of integrin receptors in human fetal
pancreatic cells shows that β1 integrin is required for
maintenance of insulin expression, cell survival, and
adhesion.15,18 Likewise, loss of α3 integrin function leads to
decreased intracellular signaling, adhesion to ECM proteins,
and insulin expression in human fetal pancreatic cells.19
In this way, integrin receptors are important components
of the human fetal pancreas, especially in regards to insulin
expression and islet development.
Fibrin is a protein found in blood clots. It is derived from
fibrinogen, and crosslinks to form a clot once the coagulation
cascade is activated and thrombin-mediated fibrinogen
cleavage occurs.20 Fibrin also contains the amino-acid motif
Arg-Gly-Asp (RGD), a ligand to a large group of integrin
receptors.21 Addition of an RGD peptide to culture has been
shown to significantly reduce isolated islet cell death.22
Culture of the adult rat insulinoma cell line, INS-1, with
RGD peptides, fibronectin, and fibrin gels leads to significant
improvements in glucose-stimulated insulin secretion and
proliferation.23,24 Blockade of αVβ3 integrin by a neutralizing
antibody resulted in significantly increased β cell apoptosis,
indicating that functional αVβ3 integrin is required for
β cell survival.24 Furthermore, three-dimensional (3D) fibrin
culture of isolated human islets significantly enhanced β cell
function and survival.25 Fibrin is able to support a 3D cellular
environment26 and promote angiogenesis,27 which may be
beneficial for human fetal pancreatic islet cell growth and
maturity during culture and/or transplantation.7
Transplantation of human fetal pancreata has been
suggested as a treatment alternative for diabetes due to its
reduced immunogenic nature.28 Indeed, transplantation of
human fetal pancreatic cells into athymic diabetic mice leads
to normo-glycemia29 and the use of fibrin may assist in graft
survival and function.25,30 Therefore, the objective of this
study is to analyze whether fibrin can promote human fetal
pancreas differentiation and proliferation in vitro and in vivo
as well as the potential mechanisms involved. We hypothesize that fibrin will promote differentiation of human fetal
pancreatic progenitor cells into insulin producing cells
through integrin αVβ3 receptor upregulation, and stimulate
angiogenesis and cell proliferation.

(C9263, Sigma, St Louis, MO, USA) at 37 °C for
30 min.5,15,18–19,31 These isolated islet-epithelial cell clusters,
composed mainly of undifferentiated epithelial cells (~70% of
the cells express SOX9 and cytokeratin 19) with some
endocrine cells (~8% of the cells express insulin or glucagon),
were cultured in CMRL media containing 10% (v/v) fetal
bovine serum (10437-010, Invitrogen, Burlington, ON,
Canada).31 To initiate polymerization, thrombin (T4648,
Sigma) was added to fibrinogen (1.8 mg/ml, F8630, Sigma), as
previously described.24 The resultant solution was quickly
inserted into wells of a 24-well plate to form a 0.1-mm
thickness gel (~150 μl of solution). Human fetal isletepithelial cell clusters plus medium were then added on top
of the fibrin gels for the 2D experimental group or tissue
culture polystyrene (TCPS) for the control group. The 3D
fibrin-cultured group had human fetal islet-epithelial cell
clusters added to the fibrinogen solution before polymerization to form a 0.3-mm 3D scaffold (~350 μl of solution). Cell
clusters were plated on TCPS, 2D fibrin, or 3D fibrin at a
density of 5 × 104 per well (24-well plates were used) and were
cultured for 1 and 2 weeks before collection for analyses.
For the mTOR inhibition study, dissociated human fetal
pancreatic cells were pretreated with 20ng/ml of rapamycin
for 30 min then plated on 2D fibrin for 48 h. Samples were
collected for protein and double immunofluorescence
analysis.
RNA Extraction and Real-Time RT-PCR (qRT-PCR)
Total RNA was extracted from 1 week fibrin-cultured human
fetal islet-epithelial cell clusters and controls using the
miRNeasy kit (217004, Qiagen, Germantown, MD, USA).
For each reverse transcription reaction, 2 μg of DNA-free
RNA was used with random hexamers/oligo-deoxythymidine
primers and superscript reverse transcriptase (Invitrogen).
Sequences of PCR primers used for RT-PCR with expected
product size are listed in Table 1. Real-time RT-PCR analyses
were performed as described previously.24 Data were normalized to levels of 18S rRNA subunit and relative gene
expression was calculated based on the 2ΔΔCT method as
PCR signals from 2D and 3D fibrin-cultured human fetal
islet-epithelial cell clusters relative to TCPS control.

MATERIALS AND METHODS
Human Fetal Islet-Epithelial Cell Culture and Fibrin Gel
Preparation
Human fetal pancreata (15–21 weeks of age) were collected
according to protocols approved by the Health Sciences
Research Ethics Board at Western University in accordance
with guidelines of the Canadian Council on Health Sciences
Research Involving Human Subjects. The collected pancreata
were dissected carefully and immediately digested using
a dissociation buffer containing collagenase V (1 mg/ml)

Electron and Immunofluorescence Microscopy
For scanning electron microscopy (SEM), human fetal
pancreata were fixed with 2.5% (v/v) glutaraldehyde at
4 °C overnight, then dehydrated with an increasing concentration gradient of ethanol. Samples were subjected to
critical point drying and gold coating, and then visualized
by a Hitachi 3400-N Variable Pressure Scanning Electron
Microscope.
For transmission electron microscopy (TEM), human fetal
pancreata were dissected, cut into small pieces, then fixed in
2.5% (v/v) glutaraldehyde in 0.1 M phosphate buffer. Postfixation was done with 1% osmium tetroxide. After dehydration through a graded ethanol series and propylene oxide
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Table 1 Sequences of primers used in real-time PCR
Gene

Accession and definition

Primer sequence

Insulin

NM_000207.1

F: 5′-TAC CTA GTG TGC GGG GAA CG-3′

Glucagon

NM_002054.2

F: 5′-GAT GAA CGA GGA CAA GCG CC-3′

PDX1

NM_001108292.1

F: 5′-CTG CTA GTA GGG AGC CTG TCG-3′

ITGB1

NM_002211.2

F: 5′-AGA GAG CTG AAG ACT ATC CCAT -3′

ITGB3

NM_000212.2

F: 5′-AAG ATT GGA GAC ACG GTG AG-3′

ITGA3

NM_002204.1

F: 5′-AGA TGC GGG CAG CCT TCG TG-3′

ITGA5

NM_002205.2

F: 5′-GGC CAG CCC TAC ATT ATC AG-3′

ITGAV

NM_002210.2

F: 5′-GGA GCA ATT CGA CGA GCA CT-3′

18S

NR_003286.2

F: 5′-GTA ACC CGT TGA ACC CCA TTC-3′

Fragment size (bp)
229

R: 5′-CTG CGG GCT GCG TCT AGT TG-3′
240

R: 5′-CCT TTC ACC AGC CAA GCA AT-3′
223

R: 5′-TGT CAG CCT CCA CTG TGT AAG-3′
313

R: 5′-CGC TGT TTT CCA ACA AGT TC-3′
394

R: 5′-AGT ACT TGC CCG TGA TCT TG-3′
484

R: 5′-GTT TTC ATG CCA GAC TCA CC-3′
303

R: 5′-GGT TCA CGG CAA AGT AGT CA-3′
246

R: 5′-ACT AAT GTT AGC AGG CGT GA-3′
151

R: 5′-CCA ′TCC AAT CGG TAG TAG CG-3′

treatment, samples were embedded in araldite medium and
cured at 65 °C overnight. Ultra-thin sections were cut at 60
nm and examined with a Philips 410 electron microscope
(Philips Electron Optics, Hillsboro, OR, USA) at 60 kV.
For immunofluorescence microscopy, human fetal pancreata and cultured human fetal islet-epithelial cell clusters
were collected and fixed in 4% (v/v) paraformaldehyde
overnight, followed by agarose embedding and wax processing. Sections (4 μm thick) were prepared and stained with
the following primary antibodies at dilutions of 1:50–100:
insulin (18-0066, Zymed, San Francisco, CA, USA), glucagon
(sc-7780, Santa Cruz Biotechnologies, CA, USA), CD31
(sc-1506, Santa Cruz Biotechnologies), PDX-1 (Dr Wright,
University of Vanderbilt, Nashville, TN, USA), Ki67 (550609,
BD Pharmingen, Mississauga, ON, Canada), cytokeratin 19
(M088801-2, Dako, Denmark), SOX9 (ab26414, Abcam, MA,
USA), and human mitochondrial surface protein (MAB1273,
Millipore, MA, USA). Fluorescent secondary antibodies were
obtained from Jackson Immunoresearch Laboratories and
used at a dilution of 1:100 (West Grove, PA, USA). The
percentage of cells expressing insulin, glucagon, SOX9 or
CK19, and Ki67 (for cell proliferation) in each experimental
group was determined. Quantification of vascularization was
done by measuring CD31-positive area and dividing it by
graft area using the Image Pro Plus software (MediaCybernetics, Rockville, MD, USA).

Protein Extraction and Western Blot Analysis
Fibrin-cultured and control cell protein was extracted in a
Nonidet-P40 lysis buffer. Equal amounts (15 μg) of lysate
protein from each experimental group were separated by 7.5,
10, or 12% (v/v) sodium dodecyl sulfate-polyacrylamide
gel electrophoresis and transferred onto a nitrocellulose
membrane (Bio-Rad Laboratories, Mississauga, ON, Canada).
Membranes were incubated with primary antibodies at
dilutions of 1:1000–5000: calnexin (610523, BD Biosciences,
Mississauga, ON, CA), actin (A2228, Sigma), GAPDH
(sc-32233, Santa Cruz Biotechnologies), PDX-1, phosphoSer473-Akt (9271, Cell Signaling, Temecula, CA, USA) and
total Akt (9272, Cell Signaling), phospho-Tyr397-FAK (3283,
Cell Signaling) and total FAK (3285, Cell Signaling),
phospho-p70s6k (9205, Cell Signaling) and total p70s6k
(9202, Cell Signaling), phospho-ERK1/2 (4370, Cell Signaling) and total ERK1/2 (9102, Cell Signaling), as well as αV
integrin (ab76609, Abcam), β3 integrin (ab75872, Abcam),
and β1 integrin (ab52971, Abcam). The application of
appropriate horseradish peroxidase-conjugated secondary
antibodies (Santa Cruz Biotechnologies) then followed.
Proteins were detected using ECL™-Plus Western blot
detection reagents (Perkin-Elmer, Wellesley, MA, USA) and
exposed using the Versadoc Imaging System (Bio-Rad
Laboratories). Densitometric quantification of bands at
subsaturation levels was performed using the Quantity One
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software (Bio-Rad Laboratories) and normalized to appropriate loading controls. Data are expressed as the relative
expression level of phosphorylated proteins to total protein
levels or protein levels to the loading control.11
Transplantation of Human Fetal Islet-Epithelial Cell
Clusters
Ten thousand freshly isolated human fetal islet-epithelial cell
clusters were mixed with 200 μl of either fibrinogen or type I
rat tail collagen before gel polymerization. Immediately
after polymerization initiation, the liquid cell-gel mixtures
were injected, subcutaneously, into the backs of 8-week-old
male nude mice (Jackson Laboratories). As controls, same
amounts of fibrin and type I rat tail collagen without cells
were injected into nude mice. Mice were killed at 1 week post
transplantation, where grafts were harvested for histological
analyses.
Statistical Analysis
Data are expressed as means ± s.d. using 4–5 different
pancreata preparations per experimental group, representing
n = 4–5. Statistical significance was determined using either
the unpaired Student’s t-test or one-way ANOVA followed by
post hoc Bonferroni comparison test. Differences were
considered as statistically significant when Po0.05.
RESULTS
The Native Human Fetal Pancreas Contained Robust
Extracellular Matrix and Integrin αvβ3 Expression
Human fetal pancreas at 16 weeks of age, analyzed by SEM,
revealed very prominent ECM fibers (Figure 1a). These fibers
surrounded cell clusters, and were also present in between
individual cells (Figure 1a). Under the TEM, ECM fibers were
often perpendicular to the cell membrane (Figure 1b). The
RGD domain containing ECM protein fibronectin was not
only frequently associated with but also present in insulinpositive cells (Figure 1c), as determined by double immunofluorescence staining. Integrin αVβ3 was highly expressed in
the developing human pancreas, and co-localized with
PDX-1, insulin, and CK19 (Figures 1d–f).

column). Quantitative RT-PCR analysis of human fetal isletepithelial cell clusters after 1 week of fibrin culture showed
significantly higher expression of PDX-1, INS, and GCG in 3D
culture (Figure 2b). Protein levels of PDX-1 in 2D and 3D
fibrin-cultured human fetal islet-epithelial cell clusters
were significantly increased during the culture period
compared with TCPS controls (Figure 2c). Fibrin-cultured
human fetal islet-epithelial cell clusters also showed
significantly higher expression of VEGF-A at 2 weeks of
culture (Figure 2d). Double immunofluorescence staining
revealed scattered clusters of insulin- and glucagon-positive
cells in all culture conditions with a slight increase in both
2D and 3D fibrin-cultured groups relative to TCPS controls
after 1 week (Figure 2e1–3). The majority of cells in all
cultured groups were SOX9 and CK19 positive (Figure 2e4, 5).
Prominent CD31-positive cells were observed in all
culture groups and maintenance of Ki67 immunoreactivity
(Figure 2e7–9).
Fibrin Increased Integrin αv and β3 Expression in Human
Fetal Islet-Epithelial Cell Clusters
To investigate the mechanism behind fibrin’s enhancement of
islet differentiation, we analyzed the expression of various
integrin receptors. At the mRNA level, 1-week cultured
human fetal islet-epithelial cell clusters had significantly
increased αV and β3 integrin expression (Figure 3a). We
further confirmed this observation by western blot and found
that the protein level of integrins αV and β3 was significantly
upregulated in human fetal islet-epithelial cell clusters
cultured with fibrin (Figures 3b and c). Expression of the
most prominent integrin, β1, was unchanged by fibrin culture
(Figure 3b).

Fibrin Enhanced PDX-1 and VEGF-A Expression While
Promoting Endocrine Cell Differentiation of Human Fetal
Islet-Epithelial Cell Clusters
Human fetal islet-epithelial cell clusters were cultured in 2D
or 3D fibrin and TCPS for up to 2 weeks. The density of
cell clusters in the TCPS group decreased during the culture
period due to lack of cell clusters adhesion. Adherent cell
clusters on the tissue culture polystyrene spread to form
monolayers (Figure 2a, left column). Cells on 2D fibrin
remained as clusters at 3 days, then began to spread at 1 week
and completely formed 2D monolayers at 2 weeks of culture
(Figure 2a, middle column). Smaller clusters with less cell
spreading were observed in 3D fibrin-cultured cells when
compared with 2D and TCPS culture groups (Figure 2a, right

Fibrin Induced PDX-1 Expression Via Increased PhosphoFocal Adhesion Kinase and p70s6k Activity in Human
Fetal Islet-Epithelial Cell Clusters
Downstream of integrin receptors, phosphorylated focal
adhesion kinase (FAK) was significantly upregulated in
human fetal islet-epithelial cell clusters during 2D and 3D
fibrin culture compared with controls (Figure 4a). No
changes were observed in pathways further downstream the
FAK pathway, including phosphorylated AKT (Figure 4b)
and extracellular-regulated kinase 1/2 (ERK1/2, Figure 4c).
However, phosphorylated p70s6k, a member of the mTOR
pathway, revealed significant upregulation in human fetal
pancreatic cells cultured with fibrin compared with controls
(Figure 4d).
Using the mTOR pathway inhibitor, rapamycin, to treat
human fetal islet-epithelial cell clusters cultured on 2D fibrin,
a significant decrease in phosphorylated p70s6k was observed
(Figure 4e). Two-dimensional fibrin cultures were used
because they were affected to the same extent as 3D fibrin
with respect to PDX-1 protein expression and signaling
pathway activity. Inhibition of the mTOR pathway resulted
in a significant decrease in PDX-1 expression, observed
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Figure 1 The human fetal pancreas contains ECM fibers and expresses integrin αvβ3. (a) Scanning electron micrographs of human fetal pancreas at
16 weeks of age show cells and clusters covered in ECM fibers. Scale bar: 50 μm (left) and 10 μm (middle). (b) Human fetal pancreas under the
transmission electron microscope at 16 weeks of age shows ECM in close proximity to the plasma membrane of cells. Scale bar: 1 μm. Black boxes refer
to enlarged images. Double immunofluorescence staining images of human fetal pancreas at 16 weeks of age show positivity for fibronectin (green)
with insulin (red) (c) and integrin αVβ3 (green) with PDX-1 (red) (d), insulin (red) (e), and CK19 (red) (f). Scale bar: 50 μm and nuclei are stained with
DAPI (blue). ECM, extracellular matrix; Endo, endocrine cell.

by western blot (Figure 4f). Furthermore, the effects of
rapamycin treatment on fibrin-cultured human fetal isletepithelial cell clusters caused a reduction in cell proliferation,
noted by cyclin D1 expression and Ki67 immunofluorescence
(Figures 4g and h).

Subcutaneous Injection of Human Fetal Islet-Epithelial
Cell Clusters with Fibrin Improved Vascularization
To investigate how fibrin could be used as a vehicle to
transplant cells subcutaneously, male nude mice were injected
with freshly isolated human islet-epithelial cell clusters cells
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mixed with fibrin immediately before polymerization
(Figure 5a). Cells mixed with collagen (Figure 5b), empty
fibrin, and empty collagen (Figure 5c) were used as controls.
A fibrin-wrapped cell graft was clearly observed under the
skin of the nude mice (Figure 5a, left) with vasculature
forming around the fibrin-wrapped graft interface (Figure 5a,
right). A collagen-wrapped cell graft was also present under
the skin of nude mice; however, vascular development was
not observed (Figure 5b). At the histological level, fibrin- and

collagen-wrapped human fetal islet-epithelial cell grafts before
and after 1 week of implantation had relatively similar levels
of insulin and glucagon positivity (Figure 5d1–3). Both fibrinand collagen-wrapped human fetal islet-epithelial cell
grafts showed higher number of SOX9/CK19-positive cells
compared with pre-implantation samples (Figure 5d4, 5). An
antibody raised against human mitochondrial surface (HMS)
protein allowed for identification of the implanted human
fetal cells. These HMS-positive cells showed a high level of cell

Figure 2 Fibrin improves human fetal pancreatic cell differentiation and increases VEGF-A expression. (a) Bright-field images of human fetal isletepithelial cell clusters cultured on tissue-culture polystyrene (TCPS), on 2D and on 3D fibrin for 3 days, 1 and 2 weeks. Scale bars: 100 μm. (b) Real-time
RT-PCR analysis of PDX-1, insulin, and glucagon mRNA expression shows significant increases in human fetal pancreatic cells cultured for 1 week with
fibrin when compared with TCPS. Western blot analysis shows significantly increased PDX-1 (c) and VEGF-A (d) expression in human fetal pancreatic
cells during 1 and 2 weeks of fibrin culture. Representative blots are shown. (e) Representative immunofluorescence images of human fetal pancreatic
cells cultured with or without fibrin and stained for insulin (red)/glucagon (green) (labeled for 1–3), SOX9 (red)/CK19 (green) (labeled for 4–6), and CD31
(red)/Ki67 (green) (labeled for 7–9). Magnified images for each corresponding image are shown in the inset. Nuclei are stained with DAPI in blue. Scale
bars: 50 μm. The percentages of positive cells are shown on the right and indicate maintained expression of these factors in fibrin-cultured cells. Data
are expressed as means ± s.d. (n = 3–5). *Po0.05, **Po0.01, and ***Po0.001 vs TCPS control.
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Figure 2 Continued.

proliferation as marked by Ki67 in both the fibrin- and
collagen-wrapped groups (Figure 5d8,9) compared with preimplantation samples (Figure 5d7). Implanted human cells in
the fibrin-wrapped group contained a large number of CD31positive cells with visible host CD31-positive cells around
the graft (Figure 5d11). The aforementioned phenomena
were not observed in the pre-implantation samples and
collagen-wrapped graft (Figure 5d10,12). Quantification of
CD31-positive area within the transplanted graft showed that
fibrin-wrapped grafts contained significantly more endothelial
cells compared with the collagen-wrapped grafts (Figure 5e).
DISCUSSION
This study investigated how fibrin can promote differentiation and proliferation of human fetal islet-epithelial cell
clusters in vitro and in vivo. The native human fetal pancreas
contains many ECM proteins, including fibronectin that may
associate with integrin αVβ3. Culture of human fetal
pancreatic cells in 2D and 3D fibrin for 1 week significantly
increased PDX-1, insulin, and glucagon expression. This was
associated with significantly higher expression of integrins αV
and β3, VEGF-A, phosphorylated FAK, and phosphorylated
p70s6k. The reduction in p70s6k phosphorylation by rapamycin treatment led to significant decreases in PDX-1 expression
and cell proliferation. Subcutaneous injection of fibrin mixed
with human fetal islet-epithelial cell clusters into nude mice
showed remarkable vascularization compared with collagen

controls. This study shows that fibrin can maintain human
fetal islet-epithelial clusters and enhance vessels formation
in vivo.
Robust ECM proteins are present in the developing human
pancreas along with integrin αVβ3. Previous studies have
indicated the presence of multiple integrin receptors in the
human fetal pancreas, which bind to the ECM to mediate
cellular responses.15 In particular, integrin β1 stimulates FAK
and ERK1/2 to promote human islet-epithelial cell differentiation and survival.18 Alongside, human islet development
requires integrins αVβ3 and αVβ5 (ref. 16) and integrin
αVβ1 (ref. 17) for adhesion and migration of cells. In mice,
the ECM component laminin-1 promotes differentiation of
pancreatic β cells,32 likely through α6 integrin.33 Culture of
β cells in hydrogels with ECM proteins improves survival
and function.34 However, loss of β cell phenotype including
diminished insulin expression occurs during long-term
culture without ECM support.35,36 In the present study,
fibrin culture of human fetal islet-epithelial cell clusters
showed only a slight increase in the number of insulin- and
glucagon-positive cells compared with controls. The possible
reasons for this observation can be explained by the following:
(1) the CMRL1066 plus 10% FBS culture medium does not
contain enough factors to sufficiently promote the differentiation of human fetal islet-epithelial cell clusters into
endocrine cells during 1 and 2 weeks of culture; (2) the
pancreatic samples from fetal age of 15–21 weeks display a
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Figure 3 Fibrin induces integrin αVβ3 expression in human fetal pancreatic cells. (a) Relative mRNA expression of integrin receptors in human fetal
pancreatic cells cultured for 1 week with fibrin shows significant increases for αv and β3 integrin when compared with cells cultured on TCPS.
(b) Representative western blots for β1, αV, and β3 integrin expression after 1 week of culture. (c) Quantitative protein expression analysis of integrins
αV and β3 in human fetal pancreatic cells during the culture period shows significant increases when human fetal pancreatic cells are cultured with
fibrin compared with TCPS. Data are expressed at means ± s.d. (n = 3–5). *Po0.05, **Po0.01, and ***Po0.001 vs TCPS control.

large number of different cell populations, and (3) immunofluorescence staining may not have sufficient sensitivity for
detecting differentiated cells since there was significantly
increased mRNA expression of these hormones, as well as a
significant increase in PDX-1 protein expression in fibrincultured cells compared with controls. As such, fibrin culture
of human islet-epithelial cells replaced, at least in part, the
ECM lost during pancreatic dissociation. This led to
improved expression of integrin receptors, signaling molecules and suggests that fibrin culture has a supportive role for
endocrine cell differentiation.
The present study demonstrated that culture of human
fetal islet-epithelial cell clusters with fibrin increased the
expression of integrins αV and β3 and downstream FAK and
p70s6k signaling molecules. Many integrin receptors on
different cell types have been shown to bind fibrin, including
integrins αVβ3 and αIIbβ3.37 We have recently shown that
fibrin culture of INS-1 cells increased expression of integrins
αV and β3, but not β1.24 These results support the notion
that stimulation of integrins with ECM can promote
cellular expression and activation of downstream signaling
pathways.12,24 At 1 week of culture, no differences in signaling
pathway activity changes were observed. However, there was a
trend toward increasing pathway phosphorylation in the
fibrin-cultured group. A reason for this could be that, despite
having significantly more integrin receptor expression, their
activation did not reach a threshold to activate enough
downstream signaling molecules to cause an effect. Yet, after

1 week of fibrin culture, the expression of insulin, glucagon,
and PDX-1 was increased, suggesting that these proteins were
being modulated by molecules other than AKT and ERK1/2.
Aberrant mTOR pathway signaling occurs in multiple
diseases states.38 We observed significant increases in
phosphorylated p70s6k when human fetal pancreatic cells
were cultured with fibrin, which was AKT independent
(Figure 4). Despite many studies confirming that the mTOR
pathway relies upon AKT, research in a pancreatic β cell line
(INS-1) showed that β cell proliferation mediated by active
mTOR/p70s6k signaling is AKT independent.39,40 We expand
on these results, suggesting that mTOR activity was
stimulated without active AKT, to modulate differentiation
of human fetal pancreatic cells. However, leucine stimulation of the mTOR pathway in fetal rat pancreatic cells led
to inefficient differentiation of Pdx-1-positive cells into
neurogenin-3-positive cells.41 This finding suggests that
mTOR activity has a negative effect on pancreatic differentiation. The major difference between our study and previous
research is the use of human cells. Numerous articles have
outlined signaling pathway differences between the rodent
and human pancreas.42–44 Also, the mTOR pathway has
different effects on the islet cell cycle depending on the animal
species.45,46 In particular, stimulation of rodent islets with
palmitate led to increased DNA synthesis (in an mTORdependent manner) in rodent islets, but not those isolated
from humans.46 Therefore, mTOR pathway activity may have
different effects on islet cell differentiation based on whether

932

Laboratory Investigation | Volume 95 August 2015 | www.laboratoryinvestigation.org

Fibrin supports fetal pancreatic differentiation
M Riopel et al

Figure 4 PDX-1 expression is regulated by mTOR signaling pathway activity. Quantitative analysis of signaling molecule activity shows significantly
increased phosphorylated FAK (a), but no change in activated AKT (b) or ERK1/2 (c) in human fetal pancreatic cells during the culture period. (d)
Phospho-p70s6k was significantly increased in fibrin-cultured human fetal pancreatic cells compared with TCPS controls. Western blot analysis of
phosphorylated p70s6k (e), PDX-1 (f) and cyclin D1 (g) expression, and (h) immunofluorescence staining of Ki67 in 2D fibrin-cultured pancreatic cells
with or without rapamycin treatment shows that PDX-1 expression is regulated, in part, through p70s6k. Arrows indicate proliferating Ki67-positive cells,
scale bar: 50 μm and nuclei are stained by DAPI (blue). Data are expressed at means ± s.d. (n = 3–5). Representative blots are shown. *Po0.05 and
**Po0.01 vs TCPS control. p, phosphorylated; t, total.

the cells are human or rodent. Our results suggest that the
mTOR pathway has a positive effect on differentiation and
proliferation of human fetal pancreatic cells when these cells
were cultured with fibrin.

When human fetal islet-epithelial cell clusters were cultured with fibrin, we observed significant increases in
VEGF-A expression (Figure 2d). We also observed angiogenesis when cells were transplanted with fibrin. The
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transplantation method used in the current study involves
transplantation of human fetal islet-epithelial cell clusters
with fibrin (or collagen) just after polymerization initiation,

then harvesting after 1 week. This experiment demonstrated
that transplanted fibrin-wrapped human fetal islet-epithelial
cell clusters can promote vasculature formation and maintain

Figure 5 Subcutaneous injection of human fetal pancreatic cells with fibrin improves vasculature. Gross demonstrations of subcutaneously injected
human fetal pancreatic cells mixed with fibrin (a) or collagen (b) in low (left) and high (right) magnification. (c) Histological image of control empty
injections of fibrin and collagen. (d) Double immunofluorescence labeled human fetal pancreatic cells either before injection (left column) or after
1 week in vivo with fibrin (middle column) or collagen (right column). Cells were stained with insulin (red)/glucagon (green) (labeled 1–3), SOX9 (red)/
CK19 (green) (labeled 4–6), Ki67 (red)/human mitochondrial surface protein (HMS, green) (labeled 7–9), and CD31 (red)/HMS (green) (labeled 10–12),
and demonstrate maintenance of differentiation and proliferation with fibrin supporting vasculature formation. Representative images are shown with
DAPI staining the nuclei (blue). Black arrows point to graft location, while white arrowheads indicate donor-derived blood vessels. Scale bars: 50 μm.
(e) Quantification of CD31-positive area in fibrin- and collagen-wrapped grafts have significantly more CD31 expressing cells than the collagen grafts.
Data are normalized to graft area and expressed at means ± s.d. (n = 3). *Po0.05 vs collagen-wrapped grafts.
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cell differentiation and proliferation. Previous reports indicate
that culturing human adult islets in fibrin for 1 week followed
by transplantation of the cells resulted in improved graft size,
reduced ductal structures, and significantly increased c-peptide levels compared with animals that received free-floating
cultured islets.25 It was postulated that the angiogenicpromoting effects of fibrin are what led to such results.
These effects have also been observed when a fibrin hydrogelislet composite was subcutaneously transplanted in mice.47
Fetal porcine islet-like cell clusters were transplanted under
the kidney capsule of nude mice and sufficient angiogenesis
occurred to develop an autonomous microcirculation
supporting these islet-like clusters.48 Likewise, normalization
of glycemia occurred when fibrin-encapsulated VEGF-treated
rat islets were transplanted into diabetic mice.49 Results from
these studies in combination with our own confirm that
blood vessel formation is important for the maintenance of
islet graft function and survival.
Fibrin has been used in many tissue-engineering specialties
as a carrier.50,51 However, as an encapsulation vehicle for
islet transplantation, fibrin has not been well characterized.
Encapsulating rat islets with fibrin, then transplanting
them into diabetic nude mice normalized glycemia with a
minimum of only 100 islet equivalents.52 Another study
found that transplantation of islets in a fibrin glue reduced
diabetic mouse blood glucose to normal levels.30 Our results
show that human fetal pancreatic cells can be cultured with
fibrin and transplanted to yield a successful graft. Taken
together, fibrin may be used as a microencapsulation scaffold
for islet transplantation to enhance outcomes.
The human fetal pancreas contains rich ECM fibers and
expression of integrin αVβ3. Fibrin improves human fetal
pancreatic cell differentiation via the mTOR pathway, which
is associated with increases in integrin αVβ3 expression.
Fibrin also improves graft vascularization when human fetal
pancreatic cells are transplanted subcutaneously. Understanding how fibrin promotes human pancreatic progenitor
differentiation will enhance existing protocols that aim to
generate functional β cells for the treatment of diabetes.
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